Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionnon-membrane spanning protein tyrosine kinase activity

JAK3 CSK PTK6

2.34e-0446523GO:0004715
GeneOntologyMolecularFunctionubiquitin protein ligase activity

RNF130 RNF150 TRIM61 RNF148 RNF149 RNF128

3.97e-04372526GO:0061630
GeneOntologyMolecularFunctionubiquitin-like protein ligase activity

RNF130 RNF150 TRIM61 RNF148 RNF149 RNF128

5.67e-04398526GO:0061659
GeneOntologyMolecularFunctionminus-end-directed microtubule motor activity

DNHD1 DNAH3

9.91e-0418522GO:0008569
GeneOntologyMolecularFunctionubiquitin-protein transferase activity

RNF130 RNF150 TRIM61 RNF148 RNF149 RNF128

1.39e-03473526GO:0004842
GeneOntologyMolecularFunctionopsonin binding

CR1L MPTX1

1.92e-0325522GO:0001846
GeneOntologyMolecularFunctionubiquitin-like protein transferase activity

RNF130 RNF150 TRIM61 RNF148 RNF149 RNF128

2.07e-03512526GO:0019787
GeneOntologyMolecularFunctiondynein light intermediate chain binding

DNHD1 DNAH3

2.41e-0328522GO:0051959
GeneOntologyMolecularFunctionprotein methyltransferase activity

KMT2D NTMT2 PRMT7

2.45e-03103523GO:0008276
GeneOntologyMolecularFunctionaminoacyltransferase activity

RNF130 RNF150 TRIM61 RNF148 RNF149 RNF128

2.50e-03532526GO:0016755
GeneOntologyMolecularFunctiontransferase activity, transferring phosphorus-containing groups

ROCK2 JAK3 KARS1 GALT CSK IRAK4 DGKG PTK6

2.76e-03938528GO:0016772
GeneOntologyMolecularFunctioncomplement binding

CR1L MPTX1

3.14e-0332522GO:0001848
DomainPA

RNF130 RNF150 RNF148 RNF149 RNF128

1.40e-0919515PF02225
DomainPA_domain

RNF130 RNF150 RNF148 RNF149 RNF128

1.40e-0919515IPR003137
DomainZnf_RING

RNF130 RNF150 KMT2D TRIM61 RNF148 RNF149 NFXL1 CHD4 RNF128

2.15e-07326519IPR001841
Domainzf-RING_2

RNF130 RNF150 RNF148 RNF149 RNF128

2.93e-0752515PF13639
DomainZF_RING_1

RNF130 RNF150 KMT2D TRIM61 RNF148 RNF149 NFXL1 RNF128

1.12e-06291518PS00518
DomainZF_RING_2

RNF130 RNF150 KMT2D TRIM61 RNF148 RNF149 NFXL1 RNF128

1.34e-06298518PS50089
DomainRING

RNF130 RNF150 KMT2D TRIM61 RNF148 RNF149 CHD4 RNF128

1.60e-06305518SM00184
Domain-

RNF130 RNF150 KMT2D TRIM61 RNF148 RNF149 CHD4 RNF128 SP140

3.07e-064495193.30.40.10
DomainZnf_RING/FYVE/PHD

RNF130 RNF150 KMT2D TRIM61 RNF148 RNF149 CHD4 RNF128 SP140

3.68e-06459519IPR013083
DomainZnf_C3HC4_RING-type

RNF130 RNF150 TRIM61 RNF148 RNF149 RNF128

7.14e-06172516IPR018957
Domainzf-C3HC4

RNF130 RNF150 TRIM61 RNF148 RNF149 RNF128

3.11e-05223516PF00097
DomainSushi

CR1L CSMD3 SVEP1

3.86e-0452513PF00084
DomainPkinase_Tyr

JAK3 CSK IRAK4 PTK6

4.22e-04129514PF07714
DomainCCP

CR1L CSMD3 SVEP1

4.31e-0454513SM00032
DomainSUSHI

CR1L CSMD3 SVEP1

4.80e-0456513PS50923
DomainSushi_SCR_CCP_dom

CR1L CSMD3 SVEP1

5.06e-0457513IPR000436
DomainSer-Thr/Tyr_kinase_cat_dom

JAK3 CSK IRAK4 PTK6

5.45e-04138514IPR001245
DomainDynein_HC_stalk

DNHD1 DNAH3

6.51e-0414512IPR024743
DomainDynein_heavy_dom-2

DNHD1 DNAH3

6.51e-0414512IPR013602
DomainDHC_N2

DNHD1 DNAH3

6.51e-0414512PF08393
DomainMT

DNHD1 DNAH3

6.51e-0414512PF12777
DomainTSP_1

ADAMTS4 SPON1 ADAMTS13

6.79e-0463513PF00090
DomainTSP1

ADAMTS4 SPON1 ADAMTS13

7.44e-0465513SM00209
DomainTSP1_rpt

ADAMTS4 SPON1 ADAMTS13

7.44e-0465513IPR000884
DomainTSP1

ADAMTS4 SPON1 ADAMTS13

7.44e-0465513PS50092
DomainZinc_finger_PHD-type_CS

NFXL1 CHD4 SP140

7.44e-0465513IPR019786
DomainDHC_fam

DNHD1 DNAH3

7.50e-0415512IPR026983
DomainDynein_heavy_dom

DNHD1 DNAH3

7.50e-0415512IPR004273
DomainDynein_heavy

DNHD1 DNAH3

7.50e-0415512PF03028
DomainThioredoxin_CS

TXNDC12 TXN

9.68e-0417512IPR017937
DomainPHD

KMT2D CHD4 SP140

1.13e-0375513PF00628
DomainZnf_PHD-finger

KMT2D CHD4 SP140

1.31e-0379513IPR019787
DomainTyrKc

JAK3 CSK PTK6

1.79e-0388513SM00219
DomainTyr_kinase_cat_dom

JAK3 CSK PTK6

1.79e-0388513IPR020635
DomainPHD

KMT2D CHD4 SP140

1.85e-0389513SM00249
DomainPeptidase_M12B_ADAM-TS

ADAMTS4 ADAMTS13

1.94e-0324512IPR013273
DomainZnf_PHD

KMT2D CHD4 SP140

1.97e-0391513IPR001965
DomainTHIOREDOXIN_1

TXNDC12 TXN

2.11e-0325512PS00194
DomainZF_PHD_2

KMT2D CHD4 SP140

2.22e-0395513PS50016
DomainZF_PHD_1

KMT2D CHD4 SP140

2.29e-0396513PS01359
DomainPROTEIN_KINASE_TYR

JAK3 CSK PTK6

2.36e-0397513PS00109
DomainTyr_kinase_AS

JAK3 CSK PTK6

2.36e-0397513IPR008266
DomainACR

ADAMTS4 ADAMTS13

2.46e-0327512SM00608
DomainADAM_Cys-rich

ADAMTS4 ADAMTS13

2.46e-0327512IPR006586
DomainhEGF

SVEP1 CRB1

2.64e-0328512PF12661
DomainThioredoxin

TXNDC12 TXN

3.23e-0331512PF00085
DomainSH2

JAK3 CSK PTK6

3.37e-03110513SM00252
DomainSH2

JAK3 CSK PTK6

3.46e-03111513PS50001
DomainSH2

JAK3 CSK PTK6

3.55e-03112513IPR000980
Domain-

JAK3 CSK PTK6

3.55e-031125133.30.505.10
DomainGal_Oxidase_b-propeller

RABEPK KLHL18

3.88e-0334512IPR015916
DomainDISINTEGRIN_1

ADAMTS4 ADAMTS13

5.34e-0340512PS00427
DomainReprolysin

ADAMTS4 ADAMTS13

5.34e-0340512PF01421
DomainADAM_MEPRO

ADAMTS4 ADAMTS13

5.34e-0340512PS50215
DomainDISINTEGRIN_2

ADAMTS4 ADAMTS13

5.34e-0340512PS50214
DomainPeptidase_M12B

ADAMTS4 ADAMTS13

5.34e-0340512IPR001590
PathwayREACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS

ADAMTS4 SPON1 ADAMTS13

1.31e-0439363M27417
PathwayREACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS

ADAMTS4 SPON1 ADAMTS13

1.31e-0439363MM15165
Pubmed

The E3 ubiquitin ligase GREUL1 anteriorizes ectoderm during Xenopus development.

RNF130 RNF150 RNF148 RNF149 RNF128

4.06e-14653512435366
Pubmed

Spontaneous Posterior Segment Vascular Disease Phenotype of a Mouse Model, rnv3, Is Dependent on the Crb1rd8 Allele.

JAK3 CRB1

2.28e-06253230372741
Pubmed

JR5558 mice are a reliable model to investigate subretinal fibrosis.

JAK3 CRB1

2.28e-06253239138242
Pubmed

Characterization of a spontaneous retinal neovascular mouse model.

JAK3 CRB1

2.28e-06253225188381
Pubmed

Compartmentalized citrullination in Muller glial endfeet during retinal degeneration.

JAK3 CRB1

6.83e-06353235197297
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

ROCK2 RHOBTB1 ADAMTS4 SPON1 PRMT7 PREX1 KLHL18

9.67e-0649353715368895
Pubmed

Cullin-3 regulates vascular smooth muscle function and arterial blood pressure via PPARĪ³ and RhoA/Rho-kinase.

ROCK2 RHOBTB1

1.36e-05453223040068
Pubmed

Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors.

ADORA2A IRAK4

1.36e-05453217974599
Pubmed

ADAMTS 1, 4, 12, and 13 levels in maternal blood, cord blood, and placenta in preeclampsia.

ADAMTS4 ADAMTS13

1.36e-05453229135310
Pubmed

Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

RHOBTB1 NUP155 SPON1 KLHL18

1.76e-051015349872452
Pubmed

RhoBTB1 interacts with ROCKs and inhibits invasion.

ROCK2 RHOBTB1

2.27e-05553231431478
Pubmed

Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase.

CSK PTK6

2.27e-05553225897081
Pubmed

Methyltransferase-like 21e inhibits 26S proteasome activity to facilitate hypertrophy of type IIb myofibers.

KARS1 CHD4 TXNDC12 AHNAK2 TXN

4.72e-0525953531162944
Pubmed

The Lyn kinase C-lobe mediates Golgi export of Lyn through conformation-dependent ACSL3 association.

GALT CSK

6.34e-05853220605918
Pubmed

Receptor Elimination by E3 Ubiquitin Ligase Recruitment (REULR): A Targeted Protein Degradation Toolbox.

RNF130 RNF128

6.34e-05853237011906
Pubmed

Polymorphisms in innate immunity genes and patients response to dendritic cell-based HIV immuno-treatment.

ROCK2 KARS1 CSK IRAK4

6.50e-0514153420056178
Pubmed

Identification and characterisation of spontaneous mutations causing deafness from a targeted knockout programme.

KMT2D KLHL18

8.15e-05953235296311
Pubmed

ADAMTS: a novel family of extracellular matrix proteases.

ADAMTS4 ADAMTS13

1.02e-041053211167130
Pubmed

Evolutionarily conserved regulators of tau identify targets for new therapies.

RNF130 NUP155 CSK RNF149 NFXL1 TXN

1.32e-0451653636610398
Pubmed

Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.

ZMYND15 TAX1BP1 PNPLA8 ADAMTS13 PREX1 KLHL18 MOB4

1.37e-0475053711230166
Pubmed

Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics.

ADAMTS4 ADAMTS13

1.49e-041253225770910
Pubmed

O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation.

ADAMTS4 SPON1 ADAMTS13

2.09e-047553320637190
Pubmed

A high-throughput candidate gene mutation screen in lymphoproliferative and myeloproliferative neoplasias.

JAK3 CSK

2.70e-041653219464057
Pubmed

The protein tyrosine kinase family of the human genome.

JAK3 CSK PTK6

2.82e-048353311114734
Pubmed

TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.

ADORA2A KARS1 NUP155 TAX1BP1 BOP1 CHD4 TXN

5.69e-0494953736574265
Pubmed

Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.

JAK3 CSK PTK6 TXN

8.37e-0427653428319085
Pubmed

Genome-wide association study identifies eight loci associated with blood pressure.

RHOBTB1 CSK

1.10e-033253219430483
Pubmed

Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.

KARS1 NUP155 RBL1 CHD4

1.20e-0330453432235678
Pubmed

Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.

RBL1 TAX1BP1 KLHL18

1.24e-0313853328786561
Pubmed

Galectin-8 Senses Phagosomal Damage and Recruits Selective Autophagy Adapter TAX1BP1 To Control Mycobacterium tuberculosis Infection in Macrophages.

TAX1BP1 TXN

1.47e-033753234225486
InteractionZMYND15 interactions

ZMYND15 CSK

6.53e-062522int:ZMYND15
GeneFamilyRing finger proteins

RNF130 RNF150 TRIM61 RNF148 RNF149 RNF128

2.91e-0527540658
GeneFamilyHyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing

CR1L CSMD3 SVEP1

2.70e-04574031179
GeneFamilyADAM metallopeptidases with thrombospondin type 1 motif

ADAMTS4 ADAMTS13

7.97e-041940250
GeneFamilyPHD finger proteins

KMT2D CHD4 SP140

1.03e-039040388
CoexpressionGSE13493_DP_VS_CD8POS_THYMOCYTE_DN

ROCK2 RABEPK JAK3 NUP155 KLHL18

5.24e-05200535M3315
CoexpressionGSE14769_20MIN_VS_360MIN_LPS_BMDM_DN

JAK3 KARS1 ADAMTS4 RBL1 TXN

5.24e-05200535M3513
CoexpressionGSE19198_1H_VS_6H_IL21_TREATED_TCELL_DN

JAK3 KARS1 ADAMTS4 RBL1 TXN

5.24e-05200535M7232
CoexpressionGSE11924_TFH_VS_TH17_CD4_TCELL_DN

ROCK2 RABEPK EXOSC1 CSMD3 CRB1

5.24e-05200535M3157
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RNF150 SPON1 NHS CDH10 SVEP1

3.26e-06192535deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCellILEUM-non-inflamed-(3)_MNP-(3)_mature_DC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

RNF150 SPON1 CSMD3 TXN

5.10e-05171534341f9f79c1ed654ab347e25dc4936f89ffdf9617
ToppCell343B-Fibroblasts-Fibroblast-H-|343B / Donor, Lineage, Cell class and subclass (all cells)

EVC2 ADAMTS4 SPON1 NHS

5.46e-051745342627c3983009839fedbc5e3f628739dc026447f4
ToppCell343B-Fibroblasts-Fibroblast-H|343B / Donor, Lineage, Cell class and subclass (all cells)

EVC2 ADAMTS4 SPON1 NHS

5.46e-05174534507a33e58f62e2b72f0bcc743e84dbd0bf705a15
ToppCelldroplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ZMYND15 ADORA2A ADAMTS13 SVEP1

5.83e-051775344672cc75225a4a23b298afa8ce439628262519db
ToppCellRV-11._Adipocyte|RV / Chamber and Cluster_Paper

ROCK2 SPON1 NHS SVEP1

5.96e-05178534278bbea5cf8f0589f71675c7a3d00679391b5253
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RNF150 SPON1 NHS SVEP1

7.68e-0519053445df8fee00f8949937863159d7aa042e72748d9b
ToppCellCOVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type

JAK3 PREX1 HELB SP140

7.83e-051915345a4ad5ae5c2dbfb225158cb598ef649c26a48350
ToppCellAdult-Immune-monocyte-D175|Adult / Lineage, Cell type, age group and donor

JAK3 RNF130 CSK PREX1

7.83e-05191534cbebb4d9550fdcd606cb3685ac9546c6b73fd422
ToppCellILEUM-non-inflamed-(5)_Plasma-(5)_IgM_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

RNF150 CHD4 CRB1

7.99e-0570533aa63c1b77a9fb15e75835cb3781f2d890f3fe328
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

JAK3 PNPLA8 SVEP1 HELB

7.99e-051925346bba80887d6f64cf913a5c22f62baaddda417ce0
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SPON1 NHS CDH10 SVEP1

8.15e-05193534fb28717fadd06c3840636d25409ce80c9254bd34
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SPON1 NHS CDH10 SVEP1

8.32e-0519453460622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCellCOVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type

RNF150 SPON1 NHS SVEP1

8.49e-051955343d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

DGKG RNF128 CSMD3 CDH10

9.18e-0519953419a97e27a4758e794ce7246d295e112b47931a48
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

DGKG RNF128 CSMD3 CDH10

9.18e-05199534333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

DGKG RNF128 CSMD3 CDH10

9.18e-05199534e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCellMS-IIF-Lymphocyte-T/NK-CD4+_CTL|IIF / Disease, condition lineage and cell class

EVC2 BOP1 CSMD3 TXN

9.18e-05199534232f85175f49322eee903dd5e7d8e5a94c751ee0
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

DGKG RNF128 CSMD3 CDH10

9.36e-05200534ad777683adeb2ce45ade570386235e311fa7ea2d
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

JAK3 PREX1 HELB SP140

9.36e-05200534c6c2b39359c65c9444987d02d1c899dff2ad1366
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

JAK3 PREX1 HELB SP140

9.36e-052005348474e5d031d25bfb8461d39fa2053da01a6304fc
ToppCellChildren_(3_yrs)-Immune-monocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

JAK3 RNF130 RNF149 PREX1

9.36e-05200534881ab995c90d75fd987d6e8f1f926a4bfcc4235f
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

JAK3 PREX1 HELB SP140

9.36e-052005349de4d6ebb7e9bee5d811519eb05913ef30f70786
ToppCellBronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

RNF150 ADAMTS4 DGKG NHS

9.36e-05200534a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

JAK3 PREX1 HELB SP140

9.36e-05200534f7a9d8b99de19e9842422bada348d940e0863645
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

JAK3 PREX1 HELB SP140

9.36e-05200534cded40d5069a6fdbd90ac9a2a0bbef11727b28d5
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

JAK3 PREX1 HELB SP140

9.36e-05200534e0cec0a844b7c1f8edee4c005af27766754e470a
DiseaseMicrophthalmos

KMT2D CRB1

1.66e-0411522C0026010
DiseaseAutistic Disorder

HTR1B CHD4 CSMD3 CDH10

1.16e-03261524C0004352
DiseaseMalignant neoplasm of breast

KMT2D TAX1BP1 RNF149 DGKG NHS CDH10 TXN

2.66e-031074527C0006142
Diseasecomplement factor H-related protein 4 measurement

SPON1 CRB1

3.40e-0349522EFO_0600091

Protein segments in the cluster

PeptideGeneStartEntry
LMPNCKWVSSLAVHP

BOP1

616

Q14137
VMPICKDACWFHLAI

HTR1B

336

P28222
WSHPPPMCKVVNCSD

CSMD3

2921

Q7Z407
TFFCPDCSHAPLWLM

ADORA2A

256

P29274
CPPAVYEVMKNCWHL

CSK

411

P41240
WEAVCNCFMPSPLHP

DNHD1

2571

Q96M86
ACSLEPCPPRWKVMS

ADAMTS13

1006

Q76LX8
HSMCIIPWPVTCASE

RABEPK

296

Q7Z6M1
VDPWLSEHCTCPMCK

RNF130

291

Q86XS8
CPAEVHELMKLCWAP

JAK3

1066

P52333
CIFHMPCIQKWAKDS

NFXL1

181

Q6ZNB6
MIWPKVECCHFKTAV

EVC2

81

Q86UK5
PISWCEMQCPKTHTK

EXOSC1

166

Q9Y3B2
NPWFCDCHISKMIEL

LRIT3

201

Q3SXY7
LWCVNHDTFPFQKPM

NUP155

431

O75694
ECPPSVHKLMLTCWC

PTK6

411

Q13882
EPWMQPCCTIKITHK

DGKG

751

P49619
MCQTKHSPWADGTPC

ADAMTS4

481

O75173
PETDCWTFMAPMACH

KLHL18

546

O94889
CHLAASWMPTLEKIC

DNAH3

3581

Q8TD57
KIKCTMAPFWAHSDP

PRMT7

291

Q9NVM4
LFWVCLPHFCSPEIM

CDH10

11

Q9Y6N8
CKVMCFHPWSDVTLP

GALT

126

P07902
AHWSMKPPICQQIFC

CR1L

461

Q2VPA4
PSPWTCLLCSVHAME

FAM25E

101

A8MYX2
CLDGTPPLSWHMRCK

IRAK4

276

Q9NWZ3
THCETLMPLCWSKPC

CRB1

296

P82279
MEKAPEGKWSCPHCE

CHD4

401

Q14839
PTEHACWAKLMRLAC

PRRT3

706

Q5FWE3
SICDLMKKPPWHLCV

HELB

366

Q8NG08
DPWLLDHRTCPMCKM

RNF150

306

Q9ULK6
PEQCIPVWMFALHSD

NTMT2

266

Q5VVY1
SALAMHECKCLWPDV

PNPLA8

636

Q9NP80
MMPECHTIPCLLSPW

SPON1

606

Q9HCB6
ESHWKVCPMCSEQFP

TAX1BP1

751

Q86VP1
WIFLCAAHKTPKECP

MOB4

106

Q9Y3A3
FICDHPQIMSPLAKW

KARS1

461

Q15046
PSPTECCHMTPWSRK

NHS

291

Q6T4R5
CCHMTPWSRKSHPPE

NHS

296

Q6T4R5
WTCFEFTLVHCPDLM

RBL1

821

P28749
CITTMAAPSWKCLPA

PREX1

1021

Q8TCU6
PWLLEHRTCPMCKCD

RNF128

306

Q8TEB7
LWDHVLPPKEMCDSC

MPTX1

96

A8MV57
ISAHKPLLICSCEWM

RHOBTB1

496

O94844
WHSESPLMCVPLDCG

SVEP1

2251

Q4LDE5
MCDCFHMVLPTWPGT

AHNAK2

1

Q8IVF2
WCGPCKMIKPFFHSL

TXN

31

P10599
IMSWKDLHDSFPCPF

TRIM61

41

Q5EBN2
IDPWLLDHRTCPMCK

RNF149

296

Q8NC42
DPWLLAHRTCPMCKC

RNF148

286

Q8N7C7
PTNCEACMKPLWHMF

ROCK2

1271

O75116
TPWNCIFCRMKESPG

SP140

726

Q13342
APWAYALLCHSMACP

ZMYND15

241

Q9H091
PLMVIIHKSWCGACK

TXNDC12

56

O95881
SPCKMSLHFCLCWPS

THEG

156

Q9P2T0
PMEELPAHSWKCKAC

KMT2D

306

O14686